Hi everyone,
I do not have much experience of monoclonal antibody production. We have just ordered an external service to produce for us. The problem is that our immunogen is only 4 aa peptides, resulting in poor binding of fusioned cells to the targeted protein. However, there is binding between these clones with a larger peptide of 15 aa containing the 4 aa of interests.
Should we give it a shot and continue the project, or terminate it?
Thank you very much for helping.
Best regards,
Ly